Advertisement

NCLAT suspends court work, after members test positive covid-19

The National Company Law Appellate Tribunal (i.e. NCLAT) has been closed until July 10 of 2020, due to after two members of the staff tested positive for Covid-19 (corona virus). The Tribunal was first closed on June 26, 2020, after a staff member was reported to have tested positive for the Covid-19. It was supposed to re-open on July 3, 2020, but then after sanitization of the entire premises, however, the period of the suspension has been extended after another case created that is another staff member tested positive.

Advertising
Advertising

After the detection of two COVID-19 cases consequently, all of the court work including virtual hearings have been suspended at National Company Law Appellate Tribunal (NCLAT)till July 10.

Advertisement

As per a Notice dated July 2, a staff member tested positive for the COVID-19 on June 26, 2020.

Thereafter, mandatory sanitization and also sealing off the NCLAT premises were carried on as well.

Advertisement
NCLAT

Additionally, a team of Doctors from the National Centre for Disease Control (NCDC) collected many test samples from the Acting Chairperson, and other Members, Officers of the Registry, and the staff who came in contact with the infected official, directly or otherwise very well.

Unfortunately, one of them has also been tested positive for the virus, as it is informed.

“.. some members of the Staff have come in direct contact with the affected person warranting following of the mandatory norms in terms of the Guidelines issued by the Government, for ensuring the personal safety of all concerned and to prevent any peril or hazard to human life it has been decided to extend the suspension of Court work to enable all concerned to observe home quarantine.”, as of the given Notice states.

Accordingly, all court work including virtual hearing as well as filing shall remain suspended till July 10.

 

Also read:-SAIL Chairman A K Chaudhary is in quarantine after he was tested positive for the COVID virus